🔎 Trials Near Me

Início › Câncer de Bexiga › Louisiana

Ensaios clínicos de Câncer de Bexiga em Louisiana

13 estudos para Câncer de Bexiga estão buscando participantes em locais em Louisiana.

Cidades em Louisiana

Texto oficial do estudo (Inglês)

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

  • Mary Bird Perkins Cancer Center - Metairie, Metairie
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07000084

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • LSU Health Baton Rouge-North Clinic, Baton Rouge
  • Our Lady of the Lake Physician Group, Baton Rouge
  • Our Lady of The Lake, Baton Rouge
  • e mais 7
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

  • Louisiana Hematology Oncology Associates LLC, Baton Rouge
  • Mary Bird Perkins Cancer Center, Baton Rouge
  • Mary Bird Perkins Cancer Center - Gonzales, Gonzales
  • e mais 1
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06770582

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

  • Southern Urology, LLC ( Site 0145), Lafayette
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06833073

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

  • University Medical Center New Orleans, New Orleans
  • Ochsner Medical Center Jefferson, New Orleans
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07061964

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Louisiana Hematology Oncology Associates LLC, Baton Rouge
  • Northshore Oncology Associates-Covington, Covington
  • Mary Bird Perkins Cancer Center - Metairie, Metairie
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT03866382

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • Mary Bird Perkins Cancer Center, Baton Rouge
  • Mary Bird Perkins Cancer Center - Metairie, Metairie
  • Ochsner Clinic Foundation, New Orleans
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07218380

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • Tulane Cancer Center, New Orleans
  • Christus Highland/ Boniol, Shreveport
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05059444

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

  • Southern Urology (Urology America), Lafayette
  • Ochsner Medical Center, New Orleans
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06567743

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

  • Southern Urology, Lafayette
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT05951179

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

  • Mary Bird Perkins Cancer Center, Baton Rouge
  • Ochsner Clinic Foundation, New Orleans
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT05614739

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

  • Louisiana Hematology Oncology Associates LLC, Baton Rouge
  • Mary Bird Perkins Cancer Center, Baton Rouge
  • Mary Bird Perkins Cancer Center - Metairie, Metairie
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07097142

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, New Orleans
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.